ALDH1A3: A marker of mesenchymal phenotype in gliomas associated with cell invasion

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Zhang, Wenlong ^a,b   Liu, Yanwei ^a,b   Hu, Huimin ^b   Huang, Hua ^b   Bao, Zhaoshi ^a,b   Yang, Pei ^a,b   Wang, Yinyan ^a,b   You, Gan ^a,b   Yan, Wei ^c   Jiang, Tao ^a,b   Wang, Jiangfei ^a   Zhang, Wei ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTOME; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE (NAD(P)+); SMALL INTERFERING RNA; TUMOR MARKER;

ADULT; ALDH1A3 GENE; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FUNCTION; GENE ONTOLOGY; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENOME ANALYSIS; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MESENCHYMOMA; MICROARRAY ANALYSIS; RNA SEQUENCE; TRANSCRIPTOMICS; TUMOR INVASION; ANTAGONISTS AND INHIBITORS; BRAIN TUMOR; CANCER GRADING; CANCER STEM CELL; CELL MOTION; CYTOLOGY; DNA MICROARRAY; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; RNA INTERFERENCE; RNA SPLICING; TUMOR CELL LINE;

ADULT; ALDEHYDE OXIDOREDUCTASES; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RNA INTERFERENCE; RNA SPLICING; RNA, MESSENGER; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, DNA;

EID: 84956660608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142856     Document Type: Article

References (26)

1. Marcato P, Dean CA, Giacomantonio CA, Lee PW. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle. 2011;10(9):9-84. PMID: 21552008.
2. Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2010;16(1):1-55. doi: 10.1158/1078-0432.CCR-09-1630 PMID: 20028757; PubMed Central PMCID: PMC2874875.
3. Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu Z, et al. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2010;19(2):2-37. doi: 10.1158/1055-9965. EPI-09-0865 PMID: 20142235; PubMed Central PMCID: PMC3544173.
4. Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, etal. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Laboratory investigation; a journal of technical methods and pathology. 2010;90(2):2-44. doi: 10.1038/labinvest.2009.127 PMID: 20010854; PubMed Central PMCID: PMC3552330.
5. Schafer A, Teufel J, Ringel F, Bettstetter M, Hoepner I, Rasper M, etal. Aldehyde dehydrogenase 1A1 - a new mediator of resistance to temozolomide in glioblastoma. Neuro-oncology. 2012;14(12):12-64. doi: 10.1093/neuonc/nos270 PMID: 23132408; PubMed Central PMCID: PMC3499020.
6. Adam SA, Schnell O, Pöschl J, Eigenbrod S, Kretzschmar HA, Tonn JC, etal. ALDH1A1 isamarkerof astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients. Brain Pathol. 2012;22(6):6-97. doi: 10.1111/j.1750-3639.2012.00592.x PMID: 22417385.
7. Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells. 2011;29(1):1-45. doi: 10.1002/stem.563 PMID: 21280157.
8. Luo Y, Dallaglio K, Chen Y, Robinson WA, Robinson SE, McCarterMD, etal. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells. 2012;30(10):2100-13. doi: 10.1002/stem.1193 PMID: 22887839; PubMed Central PMCID: PMCPMC3448863.
9. Yang ZL, Yang L, Zou Q, Yuan Y, Li J, Liang L, etal. Positive ALDH1A3 and negative GPX3 expressions are biomarkers for poor prognosis of gallbladder cancer. Disease markers. 2013;35(3):3-72. doi: 10.1155/2013/187043 PMID: 24167362; PubMed Central PMCID: PMC3774968.
10. Zhang W, Yan W, You G, Bao Z, Wang Y, Liu Y, etal. Genome-wide DNAmethylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP-primary glioblastoma. Cancer letters. 2013;328(1):1-5. doi: 10.1016/j.canlet.2012.08.033 PMID: 22960273.
11. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, etal. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer cell. 2010;17(1):1-110. doi: 10.1016/j.ccr.2009.12.020 PMID: 20129251; PubMed Central PMCID: PMC2818769.
12. Mao P, Joshi K, Li J, Kim SH, Li P, Santana-Santos L, et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(21):21-9. doi: 10.1073/pnas.1221478110 PMID: 23650391; PubMed Central PMCID: PMC3666732.
13. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, etal. The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica. 2007;114(2):2-109. doi: 10. 1007/s00401-007-0243-4 PMID: 17618441; PubMed Central PMCID: PMC1929165.
14. Yan W, Zhang W, You G, Zhang J, Han L, Bao Z, etal. Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group. Neuro Oncol. 2012;14(12):12-40. doi: 10.1093/neuonc/nos263 PMID: 23090983; PubMed Central PMCID: PMCPMC3499016.
15. Cai J, Yang P, Zhang C, Zhang W, Liu Y, Bao Z, etal. ATRXmRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples. Oncotarget. 2014;5(9):2551-61. PMID: 24810474; PubMed Central PMCID: PMC4058026.
16. Bao ZS, Chen HM, Yang MY, Zhang CB, Yu K, Ye WL, etal. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome research. 2014;24(11):1765-73. doi: 10.1101/gr.165126.113 PMID: 25135958; PubMed Central PMCID: PMC4216918.
17. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008;5(7):7-8. doi: 10.1038/nmeth.1226 PMID: 18516045.
18. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA. 2002;99(10):10-72. doi: 10.1073/pnas.082099299 PMID: 12011421; PubMed Central PMCID: PMCPMC124443.
19. Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, etal. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2(2):2-83. doi: 10.1038/35000025 PMID: 10655586.
20. Bolós V, Peinado H, Pérez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci. 2003;116(Pt3):499-511. PMID: 12508111.
21. Yokoyama K, Kamata N, Fujimoto R, Tsutsumi S, Tomonari M, Taki M, et al. Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int J Oncol. 2003;22(4):4-8. PMID: 12632084.
22. Tester AM, Ruangpanit N, Anderson RL, Thompson EW. MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelialmesenchymal transition traits. Clin Exp Metastasis. 2000;18(7):7-60. PMID: 11688960.
23. Shao C, Sullivan JP, Girard L, Augustyn A, Yenerall P, Rodriguez J, etal. Essential role of aldehyde dehydrogenase 1A3 (ALDH1A3) forthe maintenance of non-small cell lung cancerstem cells is associated with the STAT3 pathway. Clinical Cancer Research. 2014. doi: 10.1158/1078-0432.ccr-13-3292
24. Yan J, De Melo J, Cutz JC, Aziz T, Tang D. Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis. British journal of cancer. 2014;110(10):10-603. doi: 10.1038/bjc.2014.201 PMID: 24762960; PubMed Central PMCID: PMC4021532.
25. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, etal. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):1-110. doi: 10.1016/j.ccr.2009.12.020 PMID: 20129251; PubMed Central PMCID: PMCPMC2818769.
26. Raha D, Wilson TR, Peng J, Peterson D, Yue P, Evangelista M, etal. The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation. Cancer research. 2014. doi: 10.1158/0008-5472. CAN-13-3456 PMID: 24812274.